Related Experiment Video
Updated: Sep 16, 2025

Author Spotlight: A Battery of Highly Reproducible Behavioral Tests to Validate an Angelman Syndrome Murine Model
Published on: October 20, 2023
Angelman Syndrome: Multidisciplinary Management
Whitney A Bridges1, Heide S Temples2, Tracy B Lowe3
1Whitney Bridges, Graduate Student, Clemson University, Clemson, SC; Whitney Bridges, Staff Nurse at The Wonder Center, Greenville, SC.
Abstract:
Angelman syndrome is a rare genetic disorder with various phenotypes caused by the combination of genomic imprinting and loss of the maternal UBE3A gene. The case presentation involves a nine-month-old who continues with developmental delays after working with an early intervention therapist and was later diagnosed with Angelman syndrome following several specialty referrals and genetic testing. Currently, there is no cure for Angelman syndrome, only supportive symptomatic treatment. Angelman syndrome requires a multidisciplinary approach across providers who understand the complex care essential for these patients to thrive. The case study reviews the clinical presentation for early identification of infants with Angelman Syndrome, the diagnostic criteria, symptomatic management, family resources, implications for the primary care provider, and promising future therapies.
Related Concept Videos
Mania and Antimanic Drugs: Overview
Chronic Pancreatitis II: Collaborative Care
Assessment:
Drug Therapy
Antianxiety Medications
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.

